Franklin Resources’s Allergan plc AGN.PRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-317,827
Closed -$186M 1583
2017
Q4
$186M Sell
317,827
-43,801
-12% -$28.3M 0.09% 242
2017
Q3
$267M Sell
361,628
-200
-0.1% -$166K 0.13% 198
2017
Q2
$314M Buy
361,828
+100
+0% +$83.8K 0.16% 173
2017
Q1
$307M Buy
361,728
+100
+0% +$82.9K 0.16% 173
2016
Q4
$276M Sell
361,628
-5,524
-2% -$4.17M 0.14% 180
2016
Q3
$302M Hold
367,152
0.16% 168
2016
Q2
$306M Buy
367,152
+129,850
+55% +$108M 0.16% 160
2016
Q1
$218M Sell
237,302
-300
-0.1% -$287K 0.12% 209
2015
Q4
$245M Buy
237,602
+43,702
+23% +$43.9M 0.12% 189
2015
Q3
$183M Sell
193,900
-7,500
-4% -$7.82M 0.09% 242
2015
Q2
$210M Buy
+201,400
New +$211M 0.1% 233

Other funds holding AGN.PRA

Franklin Resources's AGN.PRA Position: Q1 2018 in Review

Franklin Resources sold out of Allergan plc (AGN.PRA) in Q1 2018, closing a stake of 317,827 shares — an estimated $186M sold.

Franklin Resources first reported a position in AGN.PRA in Q2 2015 and held it in 11 quarters. The position peaked at $314M in Q2 2017. 1 fund tracked by Wall St. Rank holds AGN.PRA as of Q1 2018.

  • Franklin Resources reported no remaining Allergan plc position as of Q1 2018 after selling out during the quarter.
  • Franklin Resources sold 317,827 Allergan plc shares in Q1 2018, an estimated $186M.
  • Franklin Resources first reported a position in Allergan plc in Q2 2015 and held it in 11 quarters.
  • Franklin Resources's Allergan plc position peaked at $314M in Q2 2017.
  • 1 fund tracked by Wall St. Rank held Allergan plc as of Q1 2018.

Based on Franklin Resources's 13F filing for Q1 2018, filed 10 May 2018.